- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07315308
O Bloqueio do Plano Intercostal Parasternal Profundo Reduz o Consumo de Opioides Após Esternotomia
Preoperative Ultrasound-Guided Deep Parasternal Intercostal Plane Block and Intraoperative Opioid Consumption in Adults Undergoing Cardiac Surgery Via Median Sternotomy
Median sternotomy is commonly used in cardiac surgery and is associated with significant intraoperative and postoperative pain, often requiring substantial opioid administration. High opioid use during cardiac surgery may contribute to adverse effects such as respiratory depression, delayed extubation, postoperative nausea and vomiting, and prolonged intensive care unit stay. Therefore, effective opioid-sparing strategies are an important component of modern perioperative care.
The deep parasternal intercostal plane (DPIP) block is a regional anesthesia technique that targets the anterior cutaneous branches of the intercostal nerves, which are responsible for transmitting pain from the sternum and adjacent tissues. When performed under ultrasound guidance, this block allows precise local anesthetic deposition while minimizing the risk of pleural or vascular injury.
The purpose of this randomized controlled study is to evaluate whether a preoperative ultrasound-guided DPIP block reduces intraoperative opioid consumption in adult patients undergoing elective cardiac surgery via median sternotomy. Patients will be randomly assigned to receive either a bilateral DPIP block in addition to standard general anesthesia or standard general anesthesia alone.
The primary outcome of the study is total intraoperative opioid consumption. Secondary outcomes include time to extubation, postoperative opioid consumption within the first 24 hours, postoperative pain scores, and the incidence of opioid-related adverse effects. The results of this study may help define the role of the DPIP block as part of a multimodal, opioid-sparing analgesic strategy in cardiac surgery.
Visão geral do estudo
Status
Descrição detalhada
Adequate pain control during and after cardiac surgery via median sternotomy remains challenging despite advances in perioperative care. Opioids continue to be the mainstay of analgesia; however, excessive intraoperative opioid administration has been associated with delayed extubation, respiratory complications, postoperative nausea and vomiting, and prolonged intensive care unit stay. As part of enhanced recovery protocols, regional anesthesia techniques that provide effective opioid-sparing analgesia are increasingly emphasized.
The deep parasternal intercostal plane (DPIP) block is a relatively novel ultrasound-guided regional anesthesia technique that targets the anterior cutaneous branches of the intercostal nerves within the fascial plane between the internal intercostal and transversus thoracis muscles. Compared with more proximal neuraxial or paravertebral techniques, the DPIP block offers a more localized and anatomically specific approach to sternotomy-related pain while potentially reducing the risk of serious complications.
In this prospective, randomized controlled trial, adult patients scheduled for elective cardiac surgery via median sternotomy will be allocated to one of two parallel groups. Patients in the intervention group will receive a bilateral ultrasound-guided DPIP block performed preoperatively after induction of general anesthesia, in addition to standardized general anesthesia management. Patients in the control group will receive standardized general anesthesia alone, without a regional block. Perioperative anesthetic management, including opioid administration, will follow institutional protocols and will be guided by routine clinical parameters.
The primary objective of the study is to assess the effect of the preoperative DPIP block on total intraoperative opioid consumption. Secondary objectives include evaluation of early recovery parameters such as time to extubation, postoperative opioid requirements within the first 24 hours, postoperative pain intensity, and the occurrence of opioid-related adverse events. Safety outcomes related to the block procedure will also be recorded.
This study is designed to provide clinically relevant data on the role of the DPIP block as part of a multimodal analgesic strategy in cardiac surgery. By focusing on intraoperative opioid consumption and early recovery outcomes, the trial aims to clarify whether preoperative application of this targeted regional technique can contribute to improved perioperative management and opioid-sparing anesthesia in patients undergoing median sternotomy.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Sahinbey
-
Gaziantep, Sahinbey, Turquia (Türkiye)
- Gaziantep Sehir Hastanesi
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Adults aged 18 to 65 years Scheduled to undergo elective cardiac surgery via median sternotomy Planned general anesthesia Able to provide written informed consent Sufficient cognitive capacity to participate in postoperative clinical assessments.
Exclusion Criteria:
Emergency cardiac surgery. Cardiac surgery performed through an approach other than median sternotomy. Redo sternotomy. Known allergy or hypersensitivity to amide local anesthetics. Clinically significant coagulopathy or antithrombotic treatment contraindicating regional anesthesia according to the institutional protocol.
Infection or impaired skin integrity at or near the planned block site. Unstable clinical conditions considered to increase the risk of pleural complications.
Chronic opioid use. Pre-existing chronic pain syndromes. Major musculoskeletal deformity affecting pain assessment. Neurological or psychiatric disorders preventing valid postoperative assessment.
Clinically significant peripheral neuropathy. Severe pulmonary disease. Pregnancy or lactation. Severe cognitive impairment or inability to communicate pain intensity. Refusal or inability to provide written informed consent. Inability to comply with the study protocol.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Deep Parasternal Intercostal Plane Block Group
Participants receive bilateral ultrasound-guided deep parasternal intercostal plane (DPIP) block after induction of general anesthesia and before median sternotomy, in addition to standardized general anesthesia and protocolized intraoperative opioid management. Remifentanil is titrated according to predefined clinical and hemodynamic criteria, with rescue fentanyl administered when indicated. |
Bilateral ultrasound-guided deep parasternal intercostal plane block is performed after induction of general anesthesia and before median sternotomy. Bupivacaine 0.25% is injected into the fascial plane between the internal intercostal and transversus thoracis muscles, using 10 mL (25 mg) per side, for a total volume of 20 mL and a total dose of 50 mg. Standardized general anesthesia is administered according to the institutional cardiac anesthesia protocol. Intraoperative remifentanil infusion is initiated at 0.05 µg/kg/min and titrated according to predefined clinical and hemodynamic criteria, with a maximum infusion rate of 0.2 µg/kg/min. Rescue fentanyl (0.5 µg/kg intravenously) is administered when clinically indicated according to the protocol. The same opioid titration criteria are applied in both study groups; actual opioid doses vary according to individual patient requirements. |
|
Comparador Ativo: Standard Analgesia (Control) Group
Participants receive standardized general anesthesia and the same protocolized intraoperative opioid management as the DPIP group, without any regional anesthesia technique. Remifentanil is titrated according to the same predefined clinical and hemodynamic criteria, with rescue fentanyl administered when indicated. |
Standardized general anesthesia is administered according to the institutional cardiac anesthesia protocol. Intraoperative remifentanil infusion is initiated at 0.05 µg/kg/min and titrated according to predefined clinical and hemodynamic criteria, with a maximum infusion rate of 0.2 µg/kg/min. Rescue fentanyl (0.5 µg/kg intravenously) is administered when clinically indicated according to the protocol. The same opioid titration criteria are applied in both study groups; actual opioid doses vary according to individual patient requirements. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Total Intraoperative Opioid Consumption
Prazo: From induction of general anesthesia until completion of surgery
|
Total intraoperative opioid consumption recorded from anesthesia records. In the remifentanil-based protocol, opioid consumption will be assessed primarily as total remifentanil dose, duration-normalized remifentanil consumption, and weight- and duration-normalized remifentanil consumption. Rescue fentanyl use will be recorded separately. |
From induction of general anesthesia until completion of surgery
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Intraoperative Hemodynamic Stability
Prazo: During surgery
|
Incidence of intraoperative hemodynamic instability, defined as the need for additional opioid administration or vasoactive support in response to surgical stimulation, recorded from anesthesia records. |
During surgery
|
|
Time to Extubation
Prazo: From completion of surgery to successful tracheal extubation in the intensive care unit
|
Time elapsed between the end of surgery and successful tracheal extubation, recorded in minutes. |
From completion of surgery to successful tracheal extubation in the intensive care unit
|
|
Postoperative Opioid Consumption
Prazo: First 24 hours postoperatively
|
Cumulative amount of opioids administered during the first 24 postoperative hours, expressed as intravenous morphine equivalents (mg), obtained from medical records. |
First 24 hours postoperatively
|
|
Time to First Rescue Analgesia
Prazo: Up to 24 hours postoperatively
|
Time elapsed from arrival in the intensive care unit to the administration of the first rescue analgesic medication. |
Up to 24 hours postoperatively
|
|
Block-Related Complications
Prazo: Intraoperative period and first 24 postoperative hours
|
Incidence of complications related to the parasternal intercostal plane block, including but not limited to pneumothorax, vascular puncture, local anesthetic systemic toxicity, and infection. |
Intraoperative period and first 24 postoperative hours
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Wong HMK, Chen PY, Tang GCC, Chiu SLC, Mok LYH, Au SSW, Wong RHL. Deep Parasternal Intercostal Plane Block for Intraoperative Pain Control in Cardiac Surgical Patients for Sternotomy: A Prospective Randomized Controlled Trial. J Cardiothorac Vasc Anesth. 2024 Mar;38(3):683-690. doi: 10.1053/j.jvca.2023.11.038. Epub 2023 Nov 30.
- Li Q, Liao Y, Wang X, Zhan M, Xiao L, Chen Y. Efficacy of bilateral catheter superficial parasternal intercostal plane blocks using programmed intermittent bolus for opioid-sparing postoperative analgesia in cardiac surgery with sternotomy: A randomized, double-blind, placebo-controlled trial. J Clin Anesth. 2024 Aug;95:111430. doi: 10.1016/j.jclinane.2024.111430. Epub 2024 Mar 26.
- Medeiros HJS, Rodrigue ACLF, Mueller A, Korn E, Sabouri AS. Analgesic efficacy of parasternal intercostal plane block for midline sternotomy in adult cardiac surgery: A systematic review and meta-analysis of randomized controlled trials. J Biol Methods. 2024 Nov 14;12(1):e99010033. doi: 10.14440/jbm.2024.0070. eCollection 2025.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
- Bloqueio paraesternal
- Analgesia multimodal
- Anestesia regional guiada por ultrassom
- Bloqueio do plano intercostal paraesternal profundo
- Analgesia da esternotomia
- Gestão da dor em cirurgia cardíaca
- Analgesia poupadora de opioides
- Bloqueio da parede torácica anterior
- Anestesia regional em cirurgia cardíaca
- Dor Intraoperatória
- Consumo de Opioides Intraoperatório
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 390
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data will not be shared, as the study is a single-center clinical trial and data sharing was not included in the original study protocol or approved by the institutional ethics committee. De-identified aggregate data will be reported in scientific publications.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .